Volume : 10, Issue : 07, July – 2023
Title:
19.FORMULATION DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLET DOSAGE FORM OF AMBRISENTAN
Authors :
Sai Vinay Balla*, Mr. A.Venkateswara Rao, Mrs. B.Sravanasree
Abstract :
Among the different routes of administration, the oral route of administration continues to be the most preferred route due to various advantages including ease of ingestion, avoidance of pain, versatility and most importantly patient compliance. The different dosage forms include tablets and capsules. Recently immediate release tablets have started gaining popularity and acceptance as a drug delivery system, mainly because they are easy to administer and lead to better patient compliance. The present work involves the formulation development and in-vitro evaluation of immediate release Ambrisentan tablets. First Pre-formulation studies were carried out such as FTIR, bulk and tapped density, hounars ratio, Carr’s index, the angle of repose etc. Then the tablets were prepared by direct compression using super disintegrating agents (Kyron T-314, Sodium Starch Glycolate and Crospovidone). All formulation showed compliances with Pharmacopoeial standards. The study reveals that formulations prepared by direct compression F5 formulation exhibits highest dissolution using Sodium Starch Glycolate showed faster drug release 100.07 %.
Key words: Ambrisentan, superdisintegrant, Kyron T-314, Sodium Starch Glycolate and Crospovidone and Immediate release tablet.
Cite This Article:
Please cite this article in press Sai Vinay Balla et al, Formulation Development And Evaluation Of Immediate Release Tablet Dosage Form Of Ambrisentan., Indo Am. J. P. Sci, 2023; 10 (07).
Number of Downloads : 10
References:
1. Manish Jaimini, Sonam Ranga, Amit Kumar, Sanjay Kumar Sharma, Bhupendra Singh Chauhan. A Review On Immediate Release Drug Delivery System By Using Design Of Experiment, Journal of Drug Discovery and Therapeutics 2013, 1 (12), 21-27.
2. Pande V, Karale P, Goje P and Mahanavar S. An Overview on Emerging Trends in Immediate Release Tablet Technologies. 2016, Austin Therapeutics – Volume 3 Issue 1.
3. Ghosh R, Bhuiyan MA, Dewan I, Ghosh DR, Islam A. Immediate Release Drug Delivery System (Tablets): An overview, International Research Journal of Pharmaceutical and Applied Sciences; 2012, 2: 88-94.
4. Velivela S, Mayasa V, Guptha RM, Pati NB, Ramadevi C. Formulation, Development and Evaluation of Rosuvastatin Calcium Immediate Release Tablets. European Journal of Pharmaceutical and Medical Research. 2016; 3: 351-358.
5. Gabrielsson J, Lindberg N, Lundstedt T. Multivariate Methods in Pharmaceutical Applications. Journal of Chemomatrics. 2002; 16: 141-160.
6. Dedhiya MG, Rastogi SK, Chhettry A. Lercanidipine Immediate Release Compositions. United States Patient Application. 2006; 134-212.
7. Patrik E, Barbro J. New Oral Immediate Release Dosage Form. United States Patient Application. 2006.
8. Kaur V, Mehara N. A Review on: Importance of Superdisintegrant on Immediate Release Tablets. International Journal of Research and Scientific Innovation. 2016; 3: 39-43.
9. Nyol Sandeep , Dr. M.M. Gupta. Immediate Drug Release Dosage Form: A Review. Journal of Drug Delivery & Therapeutics; 2013, 3(2), 155-161.
10. GS Banker, NR Anderson, Tablets in: The theory and practice of industrial pharmacy, Varghese publishing house, 3 rd edition, Mumbai 1987, 314-324.
11. Ansel`S Pharmaceutical Dosage Forms & Drug Delivery Systems, Eighth Edition, 227-260
12. Aulton`S Pharmaceutics, The Design & Manufacture of Medicines,Biopharmaceutics And Pharmacokinetics: A Treatise, Vallabh Prakashan, Second Edition, 315-384. 13. EL Parrot, Compression in pharmaceutical dosage form, Marcel Dekker Inc.New York,1990,2:153-182.
13. L Lachman, HA Liberman, LJ Kanig, Theory and practice of industrial pharmacy,Vargese publication house, 3rd Edition, Mumbai 1990, 293-294; 329-335.
14. J Swarbrick, JC Boylan, L Augsburger, Tablet formulation, Encyclopedia of pharmaceutical technologyx, Marcel Dekker, 3rd Edition, New York 2002, 2711.
15. Susijit Sahoo, Biswal, Omprakash Panda, Satosh Kumar Mahapatra and Goutam Kumar Jana, Fast Disslving Tablet: As A Potential Drug Delivery System, Drug Invention Today , 2010; (2): 130-133.
16. Raghavendra NGR , Development & evaluation of tablets filled – capsules system for chronotherapeutics delivery of montelukast sodium, International journal of pharmacy & technology, 2011; 3: 1702-1721.
17. Bhandari Neeraj, Kumar Abhishek, Choudhary Abhilash, Choudhary Rubia, Bala Rajni. A Review On Immediate Release Drug Delivery System.
18. Susijit Sahoo, B. Mishra, P.IK. Biswal, Omprakash Panda, Santosh Kumar Mahapatra, Goutam Kumar Jana, Fast Dissolving Tablet: As A Potential Drug Delivery System, Drug Invention Today 2010,(2), 130- 133
19. A Gupta, AK Mishra, V Gupta, P Bansal, R Singh, AK Singh, Review Article, Recent Trends of Fast Dissolving Tablet – An Overview of Formulation Technology, International Journal of Pharmaceutical & Biological Archives, 2010; 1(1): 1 – 10
20. A Review On New Generation Orodispersible Tablets And Its Future Prospective, Tanmoy Ghosh, Amitava Ghosh And Devi Prasad, International Journal of Pharmacy and Pharmaceutical Sciences , 2011; 3(1):1491.
21. Dali Shukla, Subhashis Chakraborty, Sanjay Singh, Brahmeshwar Mishra , Mouth Dissolving Tablets II: An Overview of Evaluation Techniques, www.scipharm.at.
22. Seemanchala R , Formulation & optimization of immediate release telmisartan tablets using full factorialdesign, International journals & applied pharmaceutics, 2011; 3: 20-21.
23. Pani Nihar Ranjan, Optimization and Formulation of Immediate Release Tablet of Nateglinide by Using 32 Factorial Design, International Journal of PharmTech Research, 2010; 2(3): 1978- 1984.
24. Primojel and Primellose Superdisntegrants, Product Group Overview, Www.Dmv-Fonterra- Excipients.Com.
25. Tanoy Saha, Md. Mahbubul Alam, Dilshad Noor Lira and Abu Shara Shamsur Rouf. Formulation and Evaluation of Effects of Superdisintegrants on Immediate Release Tablet of Linagliptin, a DPP-4 Inhibitor. Bangladesh Pharmaceutical Journal 24(2): 168-179, 2021 (July).
26. Dr Y. Krishna Reddy, D. Kalpana. Formulation Development and Evaluation of Immediate Release Tablet Dosage form of Sorafenib Tosylate. Asian J. Pharm. Tech. 2020; 10(1):38-42.
</div8